Overview

Raised to Date: Raised: $77,980

Deal Terms

Investment Momentum

Company Profile

Deal Summary

Financials

Total Commitments ($USD)

Platform

Republic

Start Date

12/29/2022

Close Date

03/04/2023

Min. Goal

$25,000

Max. Goal

$1,235,000

Min. Investment

$100

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    

Valuation Cap

$8,000,000

Discount

15%

Rolling Commitments ($USD)

Status

Funded

Reporting Date

03/30/2023

Days Remaining

Funded

% of Min. Goal

Funded

% of Max. Goal

Funded

Likelihood of Max

Funded

Avg. Daily Raise

$1,218

# of Investors

160

Momentum

Funded

Create a free account today to gain access to KingsCrowd analytics.

Logos provided by Clearbit

JuneBrain

Year Founded

2019

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Medium

Capital Intensity

High

Location

Baltimore, Maryland

Business Type

Growth

Company Website

JuneBrain, with a valuation of $8 million, is raising funds on Republic. The company is empowering eye care and neurology communities with its remote disease monitoring solutions. JuneBrain is making advancements in retinal imaging with its automated, high-performance, and intelligent system used for imaging and analysis of retina structure and microvasculature. The company has been awarded $1.5 million in grants from the National Science Foundation and generated revenue of $704,000 in 2022. Samantha Scott founded JuneBrain in July 2019. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for launching the hardware and software, developing strategic partnerships, and marketing.

Summary Profit and Loss Statement

	FY 2021	FY 2020
Revenue	$0	$0
COGS	$0	$0
Tax	$0	$0
Net Income	$139,921	$-96,495

Summary Balance Sheet

	FY 2021	FY 2020
Cash	$231,098	$13,225
Accounts Receivable	$0	$0
Total Assets	$231,098	$13,225
Short-Term Debt	$39,422	$61,477
Long-Term Debt	$150,000	$50,000
Total Liabilities	$189,422	$111,477

Financials as of: 12/29/2022

Create a free account today to gain access to KingsCrowd analytics.

JuneBrain Founder Samantha Scott on Retinal Imaging

At 78.9 years, the average American’s life expectancy is way higher now than it was a century ago — 53.6 for men and 54.6 for women. It’s exciting that we can all make plans to enjoy life for at least a couple extra decades. Getting older isn’t all fun and games, though — it also means more time to develop a health condition, like a neurological or retinal disease. 

JuneBrain knows how important it is to keep track of each individual’s health, and the company wants to make that easier to do. That’s why it developed a device called Neuro-i and a platform to help monitor patients’ neurological and retinal health in and out of the clinic. We reached out to founder and CEO Samantha Scott to hear about her own experience with a neurological condition and JuneBrain’s end goal. 

Note: This interview was conducted over phone and email. It has been lightly edited for clarity and length.

Read Founder Interview